{"id":"W2114451272","doi":"10.1128/cdli.7.5.728-733.2000","title":"A Double-Blind, Adjuvant-Controlled Trial of Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen (Remune) Monotherapy in Asymptomatic, HIV-1-Infected Thai Subjects with CD4-Cell Counts of >300","year":2000,"lang":"en","type":"article","venue":"Clinical and Diagnostic Laboratory Immunology","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Response Biomedical (Canada)","funders":"","keywords":"Immunogen; Asymptomatic; Medicine; Immunology; Adjuvant; CD8; Adverse effect; Viral load; Internal medicine; Adjuvant therapy; Virology; Immune system; Gastroenterology; Virus; Antibody; Chemotherapy; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007592949,0.0003175612,0.001265108,0.0002046124,0.0001128901,0.00001186732,0.0003243213,0.0005067944,0.00217906],"category_scores_gemma":[0.0004241395,0.0002330721,0.0001407271,0.0004308163,0.001159878,0.00008302784,0.00006087579,0.0004787904,0.0009290088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003351501,"about_ca_system_score_gemma":0.0004586984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001253733,"about_ca_topic_score_gemma":0.00003612598,"domain_scores_codex":[0.996885,0.0008885342,0.001199228,0.00043418,0.00009591415,0.0004971603],"domain_scores_gemma":[0.99624,0.002566477,0.0003501027,0.0005699175,0.0002267822,0.00004672153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8012218,0.008260881,0.04044095,0.00006167881,0.001522981,0.00009115274,0.0007461559,0.000008813593,0.1412247,0.0003542392,0.0004612706,0.005605383],"study_design_scores_gemma":[0.9028176,0.01370819,0.05711412,0.0001857119,0.0002761481,0.00001999024,0.0001533295,0.000004942295,0.02120936,0.0001245512,0.003889019,0.0004970357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798678,0.01629964,0.000003361079,0.00006061581,0.0003081457,0.001553209,0.0001532477,0.00004242587,0.001711611],"genre_scores_gemma":[0.994457,0.004409019,0.00001935297,0.00004408057,0.00002221631,0.000170428,0.000179371,0.00002941454,0.000669116],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1200153,"threshold_uncertainty_score":0.9998489,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02105370342383937,"score_gpt":0.3057710678158592,"score_spread":0.2847173643920198,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}